Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

23 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Altabax Articles

Novartis to pay over $72 Million to settle False Claims Act allegations related to TOBI; FDA warns of Gleevec and Altabax promo

5 May 2010

GSK to buy US derma co Steifel for $2.9B+

20 April 2009

US new drug approvals hit 24-year low

14 January 2008

GlaxoSmithKline sees flattish 2nd-qtr results, but sales helped by Advair

30 July 2007

FDA NME and BLA approvals fall to 7 for 1st half 2007, was 11 in same period 2006

30 July 2007

FDA approves GSK's Altabax for impetigo

23 April 2007

Stock Commentary - Europe - week to April 16, 2007

23 April 2007

FDA issues approvable letter for GSK's Altabax

8 January 2007

Last-minute 2006 US FDA decisions end with mostly "approvable" letters

8 January 2007

Showing 1-9 of 9 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
  • Italy's pharma market slump set to continue, warns GlobalData
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
  • Italy's pharma market slump set to continue, warns GlobalData
  • Is failure to adopt business process management putting the pharma industry at risk?

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS